Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Poznan University of Medical Sciences | OTHER |
| Medical University of Bialystok | OTHER |
| Wroclaw Medical University | OTHER |
Not provided
Not provided
Not provided
The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard of Care (Intravenous Cannula) | Experimental | obtaining intravascular access using a ready standard intravenous cannula |
|
| IO access using NIO® set | Experimental | receive an IO line in the proximal tibia localization. IO lines are placed using an FDA-approved device called an NIO®. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intravenous access | Device | obtaining intravascular access using a standard intravenous cannula |
|
| Measure | Description | Time Frame |
|---|---|---|
| successful rate of first intravascular access attempt | successful placement of intravascular device | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| time to successful access | 1 day | |
| number of attempts to successful access | number of attempts to successful access | 1 day |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jacek Smereka, PhD | Wroclaw Medical University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lazarski Univeristy | Warsaw | 02-662 | Poland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32304800 | Background | Smereka J, Szarpak L, Filipiak KJ, Jaguszewski M, Ladny JR. Which intravascular access should we use in patients with suspected/confirmed COVID-19? Resuscitation. 2020 Jun;151:8-9. doi: 10.1016/j.resuscitation.2020.04.014. Epub 2020 Apr 15. No abstract available. |
Not provided
Not provided
the investigators will add data into manuscript
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006323 | Heart Arrest |
| D004630 | Emergencies |
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Intraosseous access | Device | obtaining intravascular access using a ready intravenous NIO needle set |
|
|
| time to infusion |
time to therapy including but not limited to time to fluids, antibiotics, and antiarrythmics |
| 1 day |
| complication rates | complication rates | 1 day |
| ease of use | self-reported percentage the vocal cord visualization. A 100% score is a extremely difficult procedure. A Ease of use score of 1% means that procedure is extremely easy | 1 day |
| Preferred intravascular access method | participants were asked which method of intravascular access they would prefer in a real-life resuscitation. | 1 day |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |